RARA CRAFT DATABASE for FDA Medical Devices
510(k)K254169

FDA DEVICE FACTS

SmartSpectra Vital Signs Monitor 1.0

Presage Security, Inc. d/b/a Presage Technologies, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 18, 2026PRODUCT CODEQMECLINICAL AREACardiology

Indications for use

The Presage SmartSpectra Vital Signs Monitor is intended for non-invasive spot measurement of pulse rate and respiratory rate in healthy individuals during routine interactions with healthcare professionals such as during routine checkups. It is software assessing video footage from a fixed-installation solution (smartphone mounted in a static-mount) in admissions and examination areas of hospitals, clinics, general care, or other secured environments, where a single human face can be maintained in view, with professional healthcare oversight. The SmartSpectra system is intended for use by trained healthcare professionals and should not be used by untrained users. The SmartSpectra Vital Signs Monitor is intended for use on humans 18 to 70 years old who do not require critical care or continuous vital signs monitoring. The device is not intended to be the sole method of checking the physical health of a subject or for use on patients that have been admitted to hospitals or in ICUs.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026